Whole blood fatty acid composition differs in term versus mildly preterm infants: small versus matched appropriate

Carlo Agostoni1, Franca Marangoni, Giorgio Stival

  • 1Department of Pediatrics, University of Milan, Milan, Italy. carlo.agostoni@unimi.it

Pediatric Research
|May 7, 2008
PubMed

Insights

Whole blood fatty acid (FA) profiles are linked to infant growth. Specific FA patterns in newborns may indicate restricted intrauterine growth (IUGR) or appropriate growth for gestational age (AGA).

Area of Science:

  • Nutritional Biochemistry
  • Neonatalogy
  • Pediatric Research

Background:

  • Restricted intrauterine growth, termed small for gestational age (SGA), affects infant health.
  • Fatty acid (FA) profiles are crucial for fetal development and may be altered in SGA infants.
  • Understanding these FA differences can inform interventions for growth restriction.

Purpose of the Study:

  • To examine the relationship between whole blood FA composition and restricted intrauterine growth (small for gestational age - SGA).
  • To compare FA profiles in SGA infants versus appropriate for gestational age (AGA) infants, stratified by gestational age (term and preterm).

Main Methods:

  • Case-control study matching SGA infants with AGA infants.
  • Whole blood samples collected on day 4 and analyzed for FA percentage composition using gas chromatography.
  • Comparison of FA profiles between SGA and AGA groups, including term and preterm infants.

Main Results:

  • Preterm infants had higher levels of parent n-6 and n-3 fatty acids.
  • Docosahexaenoic acid (DHA) was higher in term appropriate for gestational age (AGA) infants compared to term SGA and preterm infants.
  • Term AGA infants showed a significantly higher DHA/alpha-linolenic acid ratio compared to all other groups.
  • Term SGA infants had lower monounsaturated FA and higher eicosapentaenoic acid levels.

Conclusions:

  • The 4-day whole blood fatty acid profile is associated with both gestational age and birth weight.
  • Specific fatty acid patterns may serve as biomarkers for restricted intrauterine growth.
  • Further research into FA supplementation could potentially mitigate the effects of growth restriction.

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...